Douglas Adkins – Research output — Research Profiles at Washington University School of Medicine

View Scopus Profile

10739

Citations

Research activity per year

177 Article
12 Review article
8 Letter
2 Chapter
More
- 1 Comment/debate
- 1 Editorial

1 results

Filter

2021
Erratum: Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus⇓unrelated head and neck cancer: A multicenter, phase II trial (CLINICAL CANCER RESEARCH2020;26:5140–52 DOI: 10.1158/1078-0432.CCR-20-1695)
Uppaluri, R., Campbell, K. M., Egloff, A. M., Zolkind, P., Skidmore, Z. L., Nussenbaum, B., Paniello, R. C., Rich, J. T., Jackson, R., Pipkorn, P., Michel, L. S., Ley, J., Oppelt, P., Dunn, G. P., Barnell, E. K., Spies, N. C., Lin, T., Li, T., Mulder, D. T. & Hanna, Y. & 24 others, Cirlan, I., Pugh, T. J., Mudianto, T., Riley, R., Zhou, L., Jo, V. Y., Stachler, M. D., Hanna, G. J., Kass, J., Haddad, R., Schoenfeld, J. D., Gjini, E., Lako, A., Thorstad, W., Gay, H. A., Daly, M., Rodig, S. J., Hagemann, I. S., Kallogjeri, D., Piccirillo, J. F., Chernock, R. D., Griffith, M., Griffith, O. L. & Adkins, D. R., Jan 1 2021, In: Clinical Cancer Research. 27, 1, p. 357 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
6 Scopus citations